Cambridge Nutritional Sciences plc
CNSL.L · LSE
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | £7,267 | £7,257 | £8,804 | £8,090 |
| - Cash | £3,594 | £4,868 | £4,520 | £2,943 |
| + Debt | £237 | £349 | £79 | £148 |
| Enterprise Value | £3,910 | £2,738 | £4,363 | £5,295 |
| Revenue | £3,863 | £4,196 | £4,134 | £4,840 |
| % Growth | -7.9% | 1.5% | -14.6% | – |
| Gross Profit | £2,389 | £2,521 | £2,484 | £2,736 |
| % Margin | 61.8% | 60.1% | 60.1% | 56.5% |
| EBITDA | -£66 | £2,077 | £121 | £286 |
| % Margin | -1.7% | 49.5% | 2.9% | 5.9% |
| Net Income | -£397 | £1,762 | -£196 | £370 |
| % Margin | -10.3% | 42% | -4.7% | 7.6% |
| EPS Diluted | -0.002 | 0.007 | -0.001 | 0.002 |
| % Growth | -123% | 1,025% | -150% | – |
| Operating Cash Flow | -£734 | £568 | -£485 | £1,222 |
| Capital Expenditures | -£183 | -£88 | -£137 | -£38 |
| Free Cash Flow | -£917 | £480 | -£622 | £1,184 |